{
    "title": "107_hr2750",
    "content": "The Medicare Home Infusion Therapy Act of 2001 aims to provide medicare beneficiaries with the option to receive infusion drug therapies at home when appropriate, ensuring high quality and efficient care. It also covers and pays for home infusion drug therapy services. The Medicare Home Infusion Therapy Act of 2001 amends Section 1861(s) of the Social Security Act to include coverage for home infusion drug therapy services. The Medicare Home Infusion Therapy Act of 2001 updates Section 1861 of the Social Security Act to define home infusion drug therapy services. Amendments include changing references to paragraphs (16) and (17) to clauses (i) and (ii) of the second sentence. The Medicare Home Infusion Therapy Act of 2001 defines home infusion drug therapy services. The Medicare Home Infusion Therapy Act of 2001 defines home infusion drug therapy services as pharmacy, nursing, and related items and services to administer infusion drug therapies safely and effectively in the home under a physician's plan of care. The Medicare Home Infusion Therapy Act of 2001 defines home infusion drug therapy services as pharmacy, nursing, and related items and services to administer infusion drug therapies safely and effectively in the home under a physician's plan of care. The act also establishes requirements for qualified suppliers to ensure the safe and effective provision of home infusion drug therapy services, including payment through a fee schedule under the Social Security Act. The Secretary shall establish a fee schedule for home infusion drug therapy services to ensure adequate payments for drug and nondrug components, reflecting various care elements for safe provision of therapy. The Secretary will consider definitions, requirements, and clinical standards for home infusion drug therapy, ensure adequate payment levels, and guarantee access to qualified providers for beneficiaries in the part B program. The Secretary will publish a list of covered home infusion drugs, including intravenous antibiotics, for therapy services under established quality of care standards. The Secretary will publish a list of covered home infusion drugs, including intravenous antibiotics, for therapy services under established quality of care standards. Infusion drug therapies can be administered safely and effectively in a home setting, including those requiring an external infusion pump and parenterally administered blood-derived products. Additionally, any other infusion drug deemed safe and effective for home administration by the Secretary will be covered. The Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 is amended to include coverage for home infusion drug therapy services, with payment at 80 percent of the actual charge or the fee schedule amount. Section 1862(a) is also amended to include additional provisions for coverage. The Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 now covers home infusion drug therapy services, with payment at 80 percent of the actual charge or fee schedule amount. Section 1862(a) is amended to include additional provisions for coverage, including criteria for services not meeting clinical care standards or including drugs not listed under section 1834(n)(3). The Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 now covers home infusion drug therapy services, with payment at 80 percent of the actual charge or fee schedule amount. Section 1862(a) is amended to include additional provisions for coverage, including criteria for services not meeting clinical care standards or including drugs not listed under section 1834(n)(3). Section 1861(n) of the Act is amended to exclude home infusion drug therapy services from the definition of durable medical equipment. The amendments made by this section will apply to items and services furnished on or after January 1, 2002, with a rule to be published in the Federal Register by that date."
}